Examining how new hospice drug policies affect costs and medication use for patients.
Impact of New Hospice Drug Policies on Expenditures, Utilization, Prescribing Quality, and Access
This study is looking at how new rules about medications in hospice care are affecting the costs and prescriptions for older Americans, so we can better understand how these changes impact patients and hospice providers.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of Massachusetts Med Sch Worcester NIH-funded |
| Lab location | 1 site (Worcester, United States) |
| Project ID | NIH-10981308 on NIH RePORTER |
What this research studies
This research investigates the effects of recent changes in hospice drug policies on medication expenditures and prescribing practices for older Americans receiving hospice care. By analyzing data from Medicare, the study aims to understand how these policy shifts impact both patients and hospice agencies. The researchers will look at medication utilization patterns before and after the policy changes to identify any significant trends or issues that arise from these new regulations.
Who could benefit from this research
Good fit: Ideal candidates for this research are older adults aged 65 and over who are currently receiving hospice services.
Not a fit: Patients who are not enrolled in Medicare or those who do not utilize hospice services may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved medication management and access for hospice patients, ensuring they receive necessary treatments without unnecessary financial burdens.
How similar studies have performed: While there have been studies on hospice care and medication management, this specific analysis of the impact of policy changes on expenditures and prescribing quality is relatively novel.
Where this research is happening
Worcester, United States
- Univ of Massachusetts Med Sch Worcester — Worcester, United States (Active)
Researchers
- Principal investigator: Tjia, Jennifer — Univ of Massachusetts Med Sch Worcester
- Study coordinator: Tjia, Jennifer
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.